Immunomagnetic Reduction Detects Plasma Aβ(1–42) Levels as a Potential Dominant Indicator Predicting Cognitive Decline

Although the concentrations of Alzheimer’s disease (AD) biomarkers Aβ(1–40), Aβ(1–42) and tau protein are very low in human plasma, ultrasensitive assays such as immunomagnetic reduction (IMR) are able to precisely quantify them. Review articles have described the detailed working mechanism of IMR a...

Descripción completa

Detalles Bibliográficos
Autores principales: Yang, Shieh-Yueh, Liu, Huei-Chun, Chen, Wen-Ping
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer Healthcare 2020
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7606390/
https://www.ncbi.nlm.nih.gov/pubmed/33090326
http://dx.doi.org/10.1007/s40120-020-00215-2

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7606390/
https://www.ncbi.nlm.nih.gov/pubmed/33090326
http://dx.doi.org/10.1007/s40120-020-00215-2

Ejemplares similares